Compare ELOG & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELOG | OSRH |
|---|---|---|
| Founded | 2006 | N/A |
| Country | China | United States |
| Employees | N/A | 21 |
| Industry | Integrated Freight & Logistics | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 11.7M |
| IPO Year | N/A | N/A |
| Metric | ELOG | OSRH |
|---|---|---|
| Price | $0.99 | $0.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.8K | ★ 827.6K |
| Earning Date | 05-12-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.84 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.80 | $0.38 |
| 52 Week High | $3.07 | $1.79 |
| Indicator | ELOG | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 66.14 |
| Support Level | $0.86 | $0.54 |
| Resistance Level | $1.19 | $0.74 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 56.44 | 93.81 |
Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products. Its segments are Transportation services and Warehouse subleasing services. The group generates the majority of its revenue from Transportation services.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.